Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia

Acute myeloid leukemia (AML); EZH2; drug resistance; epigenetic; proteasome

Saved in:
Bibliographic Details
Main Authors: Göllner, Stefanie (Author) , Müller-Tidow, Carsten (Author)
Format: Article (Journal)
Language:English
Published: 30 Mar 2017
In: Molecular & cellular oncology
Year: 2017, Volume: 4, Issue: 2, Pages: 1-3
ISSN:2372-3556
DOI:10.1080/23723556.2017.1291396
Online Access:Verlag, Volltext: https://www.tandfonline.com/doi/full/10.1080/23723556.2017.1291396
Resolving-System, Volltext: https://dx.doi.org/10.1080/23723556.2017.1291396
Get full text
Author Notes:Stefanie Göllner and Carsten Müller-Tidow
Description
Summary:Acute myeloid leukemia (AML); EZH2; drug resistance; epigenetic; proteasome
Physical Description:Online Resource
ISSN:2372-3556
DOI:10.1080/23723556.2017.1291396